Covered recipient · General Payments record
SAILAJA MAMILLA CHERUKU
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2021–2024
$1,119.65
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.23 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $253.62 | 12 |
| GENZYME CORPORATION | $38.35 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.91 | 2 |
| Ardelyx, Inc. | $17.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.67 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457036 | CMS |
| ABBVIE INC. | $21.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457038 | CMS |
| ABBVIE INC. | $20.10 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457040 | CMS |
| ABBVIE INC. | $24.74 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457042 | CMS |
| ABBVIE INC. | $32.95 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457044 | CMS |
| ABBVIE INC. | $18.11 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457046 | CMS |
| ABBVIE INC. | $23.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457048 | CMS |
| ABBVIE INC. | $23.33 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457050 | CMS |
| ABBVIE INC. | $21.47 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457052 | CMS |
| ABBVIE INC. | $5.62 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457054 | CMS |
| ABBVIE INC. | $24.08 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457056 | CMS |
| ABBVIE INC. | $19.06 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103457058 | CMS |
| Ardelyx, Inc. | $17.35 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146675196 | CMS |
| GENZYME CORPORATION | $38.35 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139783373 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.43 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137510051 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.48 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137510055 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.